# PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates

> **NCT00623740** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 523 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** hydrocortisone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00623740
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 523 (ACTUAL)
- **Last updated:** 2018-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00623740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00623740, "PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00623740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*